BHVN

Biohaven Pharmaceutical Holding Company Ltd.

Delisted

BHVN was delisted on the 3rd of October, 2022.

222 hedge funds and large institutions have $5.7B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 93 increasing their positions, 67 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$92.9M
Puts
$79.8M
Net Calls
Net Calls Change

Top Buyers

1 +$128M
2 +$89.3M
3 +$88.2M
4
AG
Artal Group
Luxembourg
+$38.8M
5
Wells Fargo
Wells Fargo
California
+$28.7M

Top Sellers

1 -$149M
2 -$97.1M
3 -$48.5M
4
KCM
Kingdon Capital Management
New York
-$44.6M
5
EP
Eversept Partners
New York
-$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$17.2M
52
$17.1M
53
$15M
54
$14.2M
55
$11.9M
56
$11.5M
57
$11.1M
58
$11M
59
$10.5M
60
$10M
61
$9.72M
62
$9.13M
63
$8.87M
64
$8.4M
65
$8.04M
66
$7.98M
67
$7.75M
68
$7.72M
69
$7.71M
70
$7.26M
71
$7.21M
72
$7.07M
73
$6.79M
74
$6.76M
75
$6.63M